介入放射学与胸部肿瘤学:二十年创新综述
本文叙述性综述2006至2026年文献,梳理影像引导诊断、经皮与血管内治疗、胸膜介入及新兴技术在胸部恶性肿瘤中的应用,强调介入放射学已从姑息辅助手段发展为多学科胸部肿瘤学的核心组成部分。
要点
- 影像引导活检从透视进展至CT、导航与机器人方法,诊断准确性高且并发症率逐步降低。
- 经皮热消融为不适合手术的早期或寡转移肺癌患者提供有效局部控制,生存与并发症表现良好。
- 介入放射学在胸膜间皮瘤的诊断、积液管理及新兴局部治疗中发挥基础作用。
核心结论
- 介入放射学已成为胸部肿瘤学不可或缺的组成部分,贯穿诊断、根治性与姑息性治疗及支持治疗。
研究设计与样本
- 叙述性综述,检索2006至2026年已发表文献,聚焦影像引导诊断技术、经皮与血管内治疗、胸膜介入及胸部恶性肿瘤相关新兴技术。
主要发现
- 影像引导活检从透视引导进展至计算机断层扫描、导航及机器人方法,实现高诊断准确性并逐步降低并发症率。
- 经皮热消融技术包括射频、微波与冷冻消融,为不适合手术的特定早期或寡转移肺癌患者提供有效局部肿瘤控制,生存与并发症表现良好。
- 血管内介入如支气管动脉栓塞与化疗栓塞为咯血及晚期疾病提供重要治疗选择。
- 在胸膜间皮瘤中,介入放射学支撑诊断、积液管理及新兴局部治疗。
- 安全性、门诊可行性与患者体验方面已有实质性改善。
临床怎么用
- 介入放射学应整合入胸部肿瘤多学科诊疗路径,覆盖诊断、根治性与姑息性治疗及支持治疗。
- 对不适合手术的早期或寡转移肺癌患者,可考虑经皮热消融作为局部控制选项。
- 血管内介入可用于咯血及晚期胸部肿瘤的治疗。
- 在胸膜间皮瘤管理中,介入放射学可用于诊断、积液管理及局部治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Since the launch of the Journal of Thoracic Oncology in 2006, interventional radiology has evolved from a predominantly palliative adjunct into a core component of multidisciplinary thoracic oncology. Advances in imaging, device engineering, and procedural techniques have expanded its role across diagnosis, treatment, and symptom control in lung cancer, pleural mesothelioma, and other intrathoracic malignancies. This review summarizes two decades of progress and clinical practice in interventional thoracic oncology. METHODS: A narrative review of the published literature from 2006 to 2026 was performed, focusing on image-guided diagnostic techniques, percutaneous and endovascular therapies, pleural interventions, and emerging technologies relevant to thoracic malignancies. Emphasis was placed on clinical outcomes, safety, patient-centered considerations, and integration within multidisciplinary care pathways. RESULTS: Image-guided biopsy techniques have progressed from fluoroscopic guidance to computed tomography based, navigational, and robotic approaches, achieving high diagnostic accuracy with progressively lower complication rates. Percutaneous thermal ablation techniques, including radiofrequency, microwave, and cryoablation, provide effective local tumor control for selected patients with early stage or oligometastatic lung cancer who are not surgical candidates, with favorable survival and morbidity profiles. Endovascular interventions, such as bronchial artery embolization and chemoembolization, offer important therapeutic options for hemoptysis and advanced disease. In pleural mesothelioma, interventional radiology underpins diagnosis, effusion management, and emerging locoregional therapies. Improvements in safety, outpatient feasibility, and patient experience have been substantial. CONCLUSIONS: Interventional radiology has become indispensable in thoracic oncology, spanning diagnosis, definitive and palliative treatments, and supportive care. Ongoing advances in artificial intelligence, robotics, and precision oncology are likely to further expand its clinical impact.
引用
- Ryan DT, Shah R, Ridge CA, et al. Interventional Radiology and Thoracic Oncology: 20 Years of Innovation. J Thorac Oncol. 2026. PMID: 42399004. doi:10.1016/j.jtho.2026.103890
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。